LAB compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

LABStandard Biotools Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

LABStandard Biotools Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LAB

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±41.1%▲+2.04%×0.05

Q1 FY26±44.5%▼−1.07%×0.02

Feb 25 '26±22.9%▲+1.74%×0.07

Jan 30 '26±18.1%▼−0.71%×0.04

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedLAB realized, solidLLY realized, hatchedOne scale, both sides: full bar = 45%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

LABStandard Biotools Inc.

0.61· pre 0.61· delayed

Mkt cap$239.4MRevenue$19MQ3 FY26Revenue$65MFY25

LLYELI Lilly & Co

1,407.25· pre 1,419.11· delayed

Pre-marketNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 4 '26delayed

LABStandard Biotools Inc.

LLYELI Lilly & Co

0.61pre 0.61delayed

Price

1,407.25pre 1,419.11delayed

$239.4M

Mkt cap

$1.3T

Q3 FY26$19M

Revenue

$24.4BQ3 FY26

FY25$65M

Revenue

$65.2BFY25

LAB0.61vsLLY1,407.25Pre-marketNov 4 '26delayed